Visiomed Group SA Share Price
Equities
ALVMG
FR0013481835
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.19 EUR | +3.26% | +0.21% | -32.86% |
03-26 | Visiomed: share price rises on 'record' 2023 results | CF |
02-13 | Visiomed: 38% increase in annual sales | CF |
Sales 2021 | 7.18M 7.68M 615M | Sales 2022 | 14.44M 15.44M 1.24B | Capitalization | 98.55M 105M 8.44B |
---|---|---|---|---|---|
Net income 2021 | -4M -4.28M -342M | Net income 2022 | -5M -5.35M -428M | EV / Sales 2021 | 1.38 x |
Net cash position 2021 | 1.62M 1.73M 138M | Net Debt 2022 | 3.26M 3.48M 279M | EV / Sales 2022 | 7.05 x |
P/E ratio 2021 |
-1.33
x | P/E ratio 2022 |
-22.7
x | Employees | 73 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99.97% |
1 day | +3.26% | ||
1 week | +0.21% | ||
Current month | -19.15% | ||
1 month | -13.95% | ||
3 months | -22.45% | ||
6 months | -19.15% | ||
Current year | -32.86% |
Managers | Title | Age | Since |
---|---|---|---|
Clement Pacaud
CEO | Chief Executive Officer | 34 | 01-21 |
Investor Relations Contact | - | - | |
Thomas Picquette
SEC | Corporate Secretary | - | 31/03/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | - | - | |
Director/Board Member | - | - | |
Thomas Picquette
SEC | Corporate Secretary | - | 31/03/22 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 0.19 | +3.26% | 951,897 |
25/04/24 | 0.184 | -1.81% | 1,739,032 |
24/04/24 | 0.1874 | -4.29% | 1,365,469 |
23/04/24 | 0.1958 | +4.71% | 1,539,347 |
22/04/24 | 0.187 | -1.37% | 764,819 |
Real-time Euronext Paris, April 26, 2024 at 04:35 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-32.86% | 59.69M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.36% | 26.25B | |
+2.07% | 26.48B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- ALVMG Stock